Welcome to the Investor Relations section of CareFusion’s website. Here, we provide access to a variety of shareholder materials, including financial and stock information, corporate governance resources and access to our presentations and events. We are committed to providing you with convenient access to these resources, and if you need additional information, please contact us.
You can also sign up to receive email alerts when new company information is available by going to CareFusion’s Email Alerts page.
To receive printed copies of CareFusion investor materials by mail, you can submit an on-line request here. You may also send an email to ir@carefusion.com with your contact information and material request.
Company Profile
CareFusion (NYSE: CFN) is a global corporation serving the health care industry with products and services that help hospitals measurably improve patient care. The company develops market-leading technologies including Alaris® infusion pumps, Pyxis® automated dispensing and patient identification systems, AVEA® and LTV® series of ventilators and respiratory products, ChloraPrep® skin prep products, MedMined™ services for data mining surveillance, V. Mueller® and Snowden-Pencer® surgical instruments and NeuroCare diagnostic products.
- Revenue increased 9 percent to $919 million
- GAAP diluted earnings per share (EPS) from continuing operations reached $0.45 and increased 17 percent on an adjusted basis to $0.49
- Company narrowed fiscal 2012 adjusted EPS guidance range to $1.75 to $1.80
SAN DIEGO, May 3, 2012 /PRNewswire/ -- CareFusion Corp. (NYSE: CFN), a leading, global medical technology company, today reported results for the three and nine months ended March 31, 2012.
"Our team execute...
SAN DIEGO and SAN CARLOS, Calif., April 23, 2012 /PRNewswire via COMTEX/ --CareFusion (NYSE: CFN), a global medical technology company, and Natus Medical Incorporated (NASDAQ: BABY), a leading provider of health care screening, diagnostic and treatment products, today announced that they have entered into an agreement to sell the CareFusion Nicolet business to Natus for a cash purchase price of approximately $58 million. Based in Madison, Wis., the Nicolet business employs more than 400 people w...
SAN DIEGO, April 2, 2012 /PRNewswire/ -- CareFusion Corporation (NYSE: CFN) today announced plans to release third quarter fiscal 2012 results on Thursday, May 3 following the close of trading on the New York Stock Exchange.
The company will host a webcast and conference call on May 3 at 2 p.m. PDT (5 p.m. EDT) to discuss the results for its third quarter fiscal 2012, ended on Mar. 31, 2012. To access the call and corresponding slide presentation, visit the Investors page at http://www.c...
SAN DIEGO, Feb. 10, 2012 /PRNewswire/ -- CareFusion Corp. (NYSE: CFN), a leading, global medical technology company, today announced that its board of directors authorized the repurchase of up to $500 million of the company's common stock.
(Logo: http://photos.prnewswire.com/prnh/20100706/CAREFUSIONLOGO)
"This share repurchase program reflects our confidence in CareFusion's growth potential and our commitment to increasing shareholder value," said Kieran Gallahue, chairman and CEO. "Wit...
Cautions Concerning Forward-Looking Statements: This website contains statements that are forward-looking and consequently are subject to risks and uncertainties. Examples of these statements include statements regarding our financial guidance, our expectations regarding hospital capital spending, our expected standup costs and other costs related to the separation from Cardinal Health and other statements regarding matters that are not historical facts. You should be aware that certain factors may affect us in the future and could cause actual results to differ materially from those expressed in these forward-looking statements. Such factors include the risk factors set forth in our Form 10-K, Form 10-Q and Form 8-K reports filed with the Securities and Exchange Commission (including all amendments to those reports) and exhibits to those reports. Except to the extent required by applicable law, we undertake no obligation to update or revise any forward-looking statement to reflect subsequent events or circumstances.
